Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Jiang S, Hillyer C, Du L. · 2020
Read Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. by Jiang S, Hillyer C, Du L. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7129017.txt.
Description
Jiang, Hillyer, and Du review neutralising antibodies against SARS-CoV-2 and other human coronaviruses, in Trends in Immunology. Neutralising antibodies block a virus from infecting cells and can serve as drugs or be the goal of vaccines. The review covers work against SARS-CoV, MERS-CoV, and the new virus.
SARS killed about 774 of 8,098 patients in 2003, and MERS had killed about 858 of 2,494 by the latest World Health Organization report cited. Antibodies that work usually target the spike protein, stopping attachment or membrane fusion. The authors survey monoclonal antibodies and related products in development, and what past coronavirus research teaches about designing them for the new outbreak.
Catalog record
| CREATOR | Jiang S, Hillyer C, Du L. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |